Small Molecule Antagonists of the σ-1 Receptor Cause Selective Release of the Death Program in Tumor and Self-Reliant Cells and Inhibit Tumor Growth <b> <i>in Vitro</i> </b> and <b> <i>in Vivo</i> </b>Barbara A. Spruce, Suzanne A. Eccles, Lorna Campbell et al.|Cancer Research|2004Cited by 165
Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule bindingAlexia F. Kalogeropulou, Dario R. Alessi, Elena Purlyte et al.|Biochemical Journal|2022Cited by 141
Golgi-IP, a tool for multimodal analysis of Golgi molecular contentRotimi Fasimoye, Monther Abu-Remaileh, Wentao Dong et al.|Proceedings of the National Academy of Sciences|2023Cited by 66
Impact of 100 LRRK2 variants linked to Parkinson’s Disease on kinase activity and microtubule bindingAlexia F. Kalogeropulou, Dario R. Alessi, Elena Purlyte et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 8
Golgi-IP, a novel tool for multimodal analysis of Golgi molecular contentRotimi Fasimoye, Monther Abu-Remaileh, Wentao Dong et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 3